SCHEMBL13655141

SCHEMBL13655141

Nc1ncc(-c2ccc(-c3cc(F)cc(F)c3)cc2)[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MASP2 O00187 1/20 0.58
LTA4H P09960 1/20 0.50
MAP4K4 O95819 2/20 0.41
SCN9A Q15858 2/20 0.40
SCN3A Q9NY46 2/20 0.38
HPGDS O60760 2/20 0.37
NOTUM Q6P988 1/20 0.37
KIT P10721 2/20 0.36
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
AOC3 Q16853 1/20 0.34
NPY5R Q15761 1/20 0.34
SCN2A Q99250 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8221175 0.85 MASP2 (0.66) MASP2LTA4HSCN9ASCN3AKIT
SCHEMBL4234350 0.83 MASP2 (0.50) MASP2LTA4HSCN9ASCN3AKIT
Hydrochloric Acid SCHEMBL4294464 0.82 MASP2 (0.49) MASP2LTA4HSCN9ASCN3AKIT
SCHEMBL13655229 0.78 MASP2 (0.92) MASP2LTA4HSCN9AHPGDSAOC3
SCHEMBL4053949 0.77 MASP2 (0.70) MASP2LTA4HSCN9ASCN3AKIT
SCHEMBL13655250 0.77 FLT3 (0.47) MASP2LTA4H
SCHEMBL13655235 0.76 SCN9A (0.62) MASP2SCN9ASCN3AKIT
Hydrochloric Acid SCHEMBL4061012 0.76 MASP2 (0.68) MASP2LTA4HSCN9ASCN3AKIT
SCHEMBL10979 0.76 MASP2 (0.68) MASP2LTA4HSCN9ASCN3ACCNB2
SCHEMBL20169742 0.74 MASP2 (0.66) MASP2LTA4HSCN9ASCN3AHPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270475-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES NORTH CAROLINA STATE UNIVERSITY (US) 2009-10-29 US disclosed
WO-2009123753-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES NORTH CAROLINA STATE UNIVERSITY (US) 2009-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270475-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES TFPI, O60361, PGLS MASP2 774/4885LTA4H 2694/4885MAP4K4 2787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.